LUIS MIGUEL
RUILOPE URIOSTE
Forscher bis um 2008
Universidad Autónoma de Madrid
Madrid, EspañaPublikationen in Zusammenarbeit mit Forschern von Universidad Autónoma de Madrid (53)
2023
-
Imbalance in Bone Morphogenic Proteins 2 and 7 Is Associated with Renal and Cardiovascular Damage in Chronic Kidney Disease
International Journal of Molecular Sciences, Vol. 24, Núm. 1
-
Prevention of cardiorenal damage: importance of albuminuria
European heart journal, Vol. 44, Núm. 13, pp. 1112-1123
2022
-
IMBALANCE IN BONE MORPHOGENIC PROTEINS 2 AND 7 IS ASSOCIATED WITH HYPERTENSION AND ARTERIAL STIFFNESS IN CHRONIC KIDNEY DISEASE
Journal of hypertension, Vol. 40, pp. e81
2020
-
Differential metabolic profile associated with the condition of normoalbuminuria in the hypertensive population
Nefrologia, Vol. 40, Núm. 4, pp. 439-445
-
Urinary metabolic signatures reflect cardiovascular risk in the young, middle-aged, and elderly populations
Journal of Molecular Medicine, Vol. 98, Núm. 11, pp. 1603-1613
2019
-
Association between renal dysfunction and metalloproteinase (MMP)-9 activity in hypertensive patients
Nefrologia, Vol. 39, Núm. 2, pp. 184-191
-
Lifetime cardiovascular risk is associated with a multimarker score of systemic oxidative status in young adults independently of traditional risk factors
Translational Research, Vol. 212, pp. 54-66
2017
2016
-
Urinary alpha-1 antitrypsin and CD59 glycoprotein predict albuminuria development in hypertensive patients under chronic renin-angiotensin system suppression
Cardiovascular Diabetology, Vol. 15, Núm. 1
2014
-
Comparison of agents that affect aldosterone action
Seminars in Nephrology, Vol. 34, Núm. 3, pp. 285-306
-
Development of albuminuria and enhancement of oxidative stress during chronic renin-angiotensin system suppression
Journal of Hypertension, Vol. 32, Núm. 10, pp. 2082-2091
-
Diuretics in the treatment of hypertension. Part 1: Thiazide and thiazide-like diuretics
Expert Opinion on Pharmacotherapy, Vol. 15, Núm. 4, pp. 527-547
-
Diuretics in the treatment of hypertension. Part 2: Loop diuretics and potassium-sparing agents
Expert Opinion on Pharmacotherapy, Vol. 15, Núm. 5, pp. 605-621
-
Night-time heart rate cut-off point definition by resting office tachycardia in untreated hypertensive patients: Data of the Spanish ABPM registry
Journal of Hypertension, Vol. 32, Núm. 5, pp. 1016-1024
-
Resistant hypertension and renal denervation. Considerations on the results of the SYMPLICITY HTN-3 trial
Revista Espanola de Cardiologia, Vol. 67, Núm. 11, pp. 881-882
2013
-
Guidelines updates in the treatment of obesity or metabolic syndrome and hypertension
Current Hypertension Reports, Vol. 15, Núm. 3, pp. 196-203
-
Resistant hypertension: From prevention to renal denervation
Medicina Clinica, Vol. 141, Núm. 1, pp. 27-28
2011
-
Abnormalities in ambulatory blood pressure monitoring in hypertensive patients with diabetes
Hypertension Research, Vol. 34, Núm. 11, pp. 1185-1189
-
New clinical concepts after the ONTARGET trial
Expert Review of Cardiovascular Therapy, Vol. 9, Núm. 6, pp. 685-689
2009
-
Control of hypertension in coronary heart disease
International Journal of Cardiology, Vol. 134, Núm. 2, pp. 245-247